✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Biocon Ltd.

BIOCON

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹63,175 Cr.
P/E
104.56

Biocon Ltd.

  • Biocon
  • Concord Biotech
  • Advanced Enzyme
  • TJI Pharma

FAQs on Biocon Ltd. Shareprice

Biocon has given better returns compared to its competitors.
Biocon has grown at ~20.7% over the last 2yrs while peers have grown at a median rate of 7.36%

Yes, Biocon is expensive.
Latest PE of Biocon is 105, while 3 year average PE is 60.48.
Also latest EV/EBITDA of Biocon is 21.5 while 3yr average is 19.11.

View FAQ's On Business

Growth Table

  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Balance Sheet

  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Cash Flow

  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Quarterly Results

  • Biocon Ltd.
  • Concord Biotech
  • Advanced Enzyme

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Biocon Ltd. Financials

Balance sheet of Biocon is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Biocon is increasing.
Latest net debt of Biocon is ₹11,307 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹9,515 Crs.

No, profit is decreasing.
The profit of Biocon is ₹630 Crs for TTM, ₹1,013 Crs for Mar 2025 and ₹1,022 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biocon latest dividend payout ratio is 5.92% and 3yr average dividend payout ratio is 16.91%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech